Evolent Health, Inc (EVH) financial statements (2020 and earlier)

Company profile

Business Address 800 NORTH GLEBE RD, SUITE 500
ARLINGTON, VA 22203
State of Incorp. DE
Fiscal Year End December 31
SIC 8741 - Management Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments206228238179155
Cash and cash equivalents97228238135146
Short-term investments4  449
Other undisclosed cash, cash equivalents, and short-term investments105    
Restricted cash and investments10115562345
Receivables7278755120
Contract with customer, asset12
Other undisclosed current assets(73)24314
Total current assets:308488378265184
Noncurrent Assets
Operating lease, right-of-use asset76
Property, plant and equipment8374513113
Long-term investments and receivables71132245
Long-term investments7162245
Accounts and financing receivable, after allowance for credit loss07   
Intangible assets, net (including goodwill)1,0891,103869885772
Goodwill772768628627609
Intangible assets, net (excluding goodwill)317335241259163
Contract with customer, asset, net11
Capitalized contract cost, net3019
Restricted cash and investments86362
Other noncurrent assets8    
Other undisclosed noncurrent assets4018910 
Total noncurrent assets:1,4061,234935935831
TOTAL ASSETS:1,7141,7221,3131,2001,016
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18922110811145
Accounts payable120147434417
Accrued liabilities424930296
Employee-related liabilities2725353822
Deferred revenue23
Debt5    
Due to related parties11   
Deferred revenue and credits252015
Contract with customer, liability21
Other undisclosed current liabilities4227   
Total current liabilities:26026913313260
Noncurrent Liabilities
Long-term debt and lease obligation71    
Operating lease, liability71
Liabilities, other than long-term debt3119123621
Deferred revenue0
Contract with customer, liability2
Deferred tax liabilities, net 22121
Deferred income tax liabilities25
Other liabilities71710150
Other undisclosed noncurrent liabilities228245121120 
Total noncurrent liabilities:33026413415621
Total liabilities:59053326628881
Stockholders' equity
Stockholders' equity attributable to parent, including:1,1081,1441,011703649
Additional paid in capital1,1621,093924555342
Accumulated other comprehensive loss(0)(0)   
Retained earnings (accumulated deficit)(54)5086147307
Other undisclosed stockholders' equity attributable to parent11111
Stockholders' equity attributable to noncontrolling interest164635210285
Total stockholders' equity:1,1241,1891,046912935
TOTAL LIABILITIES AND EQUITY:1,7141,7221,3131,2001,016

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues80362743525497
Revenue, net43525497
Cost of revenue
(Policyholder Benefits and Claims Incurred, Net)
 (1)   
Other undisclosed gross profit(1)    
Gross profit:80262643525497
Operating expenses(908)(675)(508)(492)(140)
Other undisclosed operating income11   
Operating loss:(105)(47)(73)(237)(43)
Nonoperating income342 414
Investment income, nonoperating432 414
Interest and debt expense(14)(5)(4)  
Income (loss) from continuing operations before equity method investments, income taxes:(116)(49)(75)(237)371
Loss from equity method investments(8)(5)(2)(1)(28)
Other undisclosed income from continuing operations before income taxes  010
Income (loss) from continuing operations before income taxes:(124)(54)(76)(238)343
Income tax expense (benefit)(0)(0)711(23)
Net income (loss):(124)(54)(70)(227)320
Net income attributable to noncontrolling interest3296713
Net income (loss) attributable to parent:(121)(53)(61)(160)332
Preferred stock dividends and other adjustments    (2)
Net income (loss) available to common stockholders, basic:(121)(53)(61)(160)330
Convertible preferred dividends    2
Other undisclosed net loss available to common stockholders, diluted    (13)
Net income (loss) available to common stockholders, diluted:(121)(53)(61)(160)320

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(124)(54)(70)(227)320
Other undisclosed comprehensive income (loss)0(0)   
Comprehensive income (loss):(124)(54)(70)(227)320
Comprehensive income, net of tax, attributable to noncontrolling interest3296713
Comprehensive income (loss), net of tax, attributable to parent:(121)(53)(61)(160)332

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: